1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SFN CTRPv2 pan-cancer AAC 0.21 6e-06
mRNA CTSV CTRPv2 pan-cancer AAC 0.18 6e-06
mRNA MIA-RAB4B CTRPv2 pan-cancer AAC 0.2 6e-06
mRNA PAK6 CTRPv2 pan-cancer AAC 0.19 6e-06
mRNA C1orf106 CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA TRIM51 CTRPv2 pan-cancer AAC 0.19 7e-06
mRNA PSMC3IP CTRPv2 pan-cancer AAC -0.17 7e-06
mRNA PKP3 CTRPv2 pan-cancer AAC 0.22 7e-06
mRNA EID2B CTRPv2 pan-cancer AAC -0.18 7e-06
mRNA C1orf116 CTRPv2 pan-cancer AAC 0.19 8e-06
Download CSV